ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma.

Patrick Schöffski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.